Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys

Anke Joas*, Lisbeth E. Knudsen, Marike Kolossa-Gehring, Ovnair Sepai, Ludwine Casteleyn, Greet Schoeters, Jürgen Angerer, Argelia Castaño, Dominique Aerts, Pierre Biot, Milena Horvat, Louis Bloemen, M. Fátima Reis, Ioana Rodica Lupsa, Andromachi Katsonouri, Milena Cerna, Marika Berglund, Pierre Crettaz, Peter Rudnai, Katarina HalzlovaMaurice Mulcahy, Arno C. Gutleb, Marc E. Fischer, Georg Becher, Nadine Fréry, Genon Jensen, Lisette Van Vliet, Holger M. Koch, Elly Den Hond, Ulrike Fiddicke, Marta Esteban, Karen Exley, Gerda Schwedler, Margarete Seiwert, Danuta Ligocka, Philipp Hohenblum, Soterios Kyrtopoulos, Maria Botsivali, Elena DeFelip, Claude Guillou, Fabiano Reniero, Regina Grazuleviciene, Toomas Veidebaum, Thit A. Mørck, Jeanette K.S. Nielsen, Janne F. Jensen, Teresa C. Rivas, Jinny Sanchez, Gudrun Koppen, Roel Smolders, Szilvia Kozepesy, Adamos Hadjipanayis, Andrea Krskova, Rory Mannion, Marek Jakubowski, J. Aleksandra Fucic, Jose Pereira-Miguel, Anca E. Gurzau, Michal Jajcaj, Darja Mazej, Janja Snoj Tratnik, Andrea Lehmann, Kristin Larsson, Birgit Dumez, Reinhard Joas

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


The potential of Human Biomonitoring (HBM) in exposure characterisation and risk assessment is well established in the scientific HBM community and regulatory arena by many publications. The European Environment and Health Strategy as well as the Environment and Health Action Plan 2004-2010 of the European Commission recognised the value of HBM and the relevance and importance of coordination of HBM programmes in Europe. Based on existing and planned HBM projects and programmes of work and capabilities in Europe the Seventh Framework Programme (FP 7) funded COPHES (COnsortium to Perform Human Biomonitoring on a European Scale) to advance and improve comparability of HBM data across Europe. The pilot study protocol was tested in 17 European countries in the DEMOCOPHES feasibility study (DEMOnstration of a study to COordinate and Perform Human biomonitoring on a European Scale) cofunded (50%) under the LIFE+ programme of the European Commission. The potential of HBM in supporting and evaluating policy making (including e.g. REACH) and in awareness raising on environmental health, should significantly advance the process towards a fully operational, continuous, sustainable and scientifically based EU HBM programme. From a number of stakeholder activities during the past 10 years and the national engagement, a framework for sustainable HBM structure in Europe is recommended involving national institutions within environment, health and food as well as European institutions such as ECHA, EEA, and EFSA. An economic frame with shared cost implications for national and European institutions is suggested benefitting from the capacity building set up by COPHES/DEMOCOPHES.

Original languageEnglish
Pages (from-to)42-57
Number of pages16
JournalEnvironmental Research
Publication statusPublished - 1 Aug 2015

Bibliographical note

Funding Information:
DEMOCOPHES ( LIFE09 ENV/BE/000410 ) was coordinated by the Federal Public Service Health, Food Chain Safety and Environment, Belgium and was jointly financed by the European Commission LIFE+ programme (50%) and national institutions in each participating country.

Funding Information:
COPHES was coordinated by BiPRO GmbH, Germany, with the University of Leuven, Belgium and was funded by DG Research in the Seventh Framework Programme ( FP7/2007-2013 ).

Publisher Copyright:
© 2014 Elsevier Inc.


  • Decision scheme
  • European platform
  • HBM
  • Policy
  • Prioritisation
  • Resources


Dive into the research topics of 'Policy recommendations and cost implications for a more sustainable framework for European human biomonitoring surveys'. Together they form a unique fingerprint.

Cite this